Myovant Sciences Ltd

NYSE:MYOV  
13.50
-0.39 (-2.81%)
Earnings Announcements

Myovant Sciences Announces Preliminary Q3 Results

Published: 01/10/2022 13:01 GMT
Myovant Sciences Ltd (MYOV) - Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Year 2021.
Myovant Sciences Ltd - Net Product Revenue Estimated to Be in Range of $28.8-$29.8 Million in Fiscal Q3 2021.
Myovant Sciences Ltd - Total Revenue for Three Months Ended December 31, 2021 is Estimated to Be in Range of $54.0-$55.0 Million.
Revenue is expected to be $59.09 Million
Adjusted EPS is expected to be -$0.56

Next Quarter Revenue Guidance is expected to be $64.39 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.